ClinicalTrials.Veeva

Menu

Clinical Features of Smoker Patients With Chronic Obstructive Pulmonary Disease

I

Izmir Katip Celebi University

Status

Unknown

Conditions

Copd
Smoking

Treatments

Other: Clinical Tests

Study type

Interventional

Funder types

Other

Identifiers

NCT04711629
IKCU-INAZ

Details and patient eligibility

About

Smoking is the most important factor in the etiology of COPD. Some of the patients with COPD continue to smoke despite knowing this situation or they cannot quit even if they want.

The aim of this study is; To examine patients with COPD who continue to smoke in terms of perception of dyspnea, exercise capacity, psychological symptoms and quality of life.

Full description

The study was designed prospectively. Patients with COPD who apply to the pulmonary rehabilitation outpatient clinic will be included.

The data of patients with COPD who are eligible for PR and have been pre-evaluated will be scanned. Respiratory function test, arterial blood gas analysis, six-minute walking test (6-MWT), mMRC Dyspnea Scale, St George Quality of Life Questionnaire and Hospital Anxiety Depression Scale will be used in the study. Patients with COPD who smoke will constitute the study group, and those who quit smoking will constitute the control group.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Smoker COPD Patients who smoker

Exclusion criteria

  • Not volunteer to participate the study

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Smoker COPD
Experimental group
Description:
Patients who continue to smoke
Treatment:
Other: Clinical Tests
Ex-smoker COPD
Active Comparator group
Description:
Patients who quit smoking.
Treatment:
Other: Clinical Tests

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems